Osaic Holdings’s ProPhase Labs PRPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-200
Closed -$809 7853
2025
Q1
$809 Buy
+200
New +$918 ﹤0.01% 6880
2024
Q4
Sell
-200
Closed -$4.84K 7573
2024
Q3
$4.84K Hold
200
﹤0.01% 6210
2024
Q2
$8.36K Hold
200
﹤0.01% 5892
2024
Q1
$12.9K Sell
200
-100
-33% -$5.07K ﹤0.01% 5615
2023
Q4
$13.6K Sell
300
-100
-25% -$4.56K ﹤0.01% 5688
2023
Q3
$17.5K Buy
400
+50
+14% +$2.93K ﹤0.01% 5624
2023
Q2
$25.4K Sell
350
-360
-51% -$29.3K ﹤0.01% 5411
2023
Q1
$54.1K Buy
710
+70
+11% +$5.64K ﹤0.01% 4894
2022
Q4
$62K Buy
640
+10
+2% +$1.08K ﹤0.01% 4780
2022
Q3
$71K Buy
630
+208
+49% +$24.2K ﹤0.01% 4648
2022
Q2
$54K Buy
+422
New +$37.1K ﹤0.01% 4896

Other funds holding PRPH

Osaic Holdings's PRPH Position: Q2 2025 in Review

Osaic Holdings sold out of ProPhase Labs (PRPH) in Q2 2025, closing a stake of 200 shares — an estimated $809 sold.

Osaic Holdings first reported a position in PRPH in Q2 2022 and held it in 11 quarters. The position peaked at $71K in Q3 2022. 33 funds tracked by Wall St. Rank hold PRPH as of Q2 2025.

  • Osaic Holdings reported no remaining ProPhase Labs position as of Q2 2025 after selling out during the quarter.
  • Osaic Holdings sold 200 ProPhase Labs shares in Q2 2025, an estimated $809.
  • Osaic Holdings first reported a position in ProPhase Labs in Q2 2022 and held it in 11 quarters.
  • Osaic Holdings's ProPhase Labs position peaked at $71K in Q3 2022.
  • 33 funds tracked by Wall St. Rank held ProPhase Labs as of Q2 2025.

Based on Osaic Holdings's 13F filing for Q2 2025, filed 13 Aug 2025.